Register to receive a free U.S. Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices Market report synopsis and brochure

In 2015, the majority of revenues in the U.S. augmentation and reconstructive implant market are derived from breast augmentation implants. This is due to the large demand for breast augmentation, coupled with the greater cost of the devices.

Global demand for breast implants has been rising since their introduction in 1962.Unit growth for breast implants has been positively driven by FDA approval of silicone devices in 2006. A key contributing factor to this rise is the influence of the North American media. Breast, facial and body augmentation has become a cultural norm, and these procedures are actively advocated by surgeons.

In 2015, the total market for augmentation and reconstructive implants was over $1.2 billion. The segment with the fastest unit growth was the pectoral implant market due to sales of silicone breast implants. This trend has been driven by popular media influences such as television shows, movies and music videos.

Owing to the specialized nature of the devices and the barrier to entry into this market resulting from FDA oversight, the average selling price per device is not expected to decrease over time. This price represents an average of the price for silicone and saline implants; saline implants are significantly less expensive than silicone implants. The ASP has been increasing since the economic recession of 2008 and 2009, when the price was dropped to maintain sales volume. Further contributing to this is the relative scarcity of raw material suppliers. There are only a handful of sources that provide the U.S. market with the appropriate grade of silicone for these devices.

Allergan held nearly 50% of the total augmentation and reconstructive implant market. The company sells silicone gel and saline implants under the Natrelle brand, and offers a warranty program for its patients in order to alleviate concerns with long-term implantation durability. Allergan acquired Inamed in 2006; it is through this transaction that Allergan gained entrance into the aesthetic implant device market and now sells almost 1,000 different variations of its implants globally. Other competitors in the market include Implantech, Medical Device Resource, AART Inc., Sientra Inc., and Nagor Ltd among others.

For Further Information
More on the breast implant market in the U.S. can be found in the report published by iData entitled U.S. Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices Market. The market segments covered in this report include botulinum toxin A market, dermal filler market, augmentation and reconstructive implant market, fat-reduction device market, and aesthetic laser and light therapy market.

The iData series on Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices covers the U.S., Australia, Japan, South Korea and 15 countries in Europe encompassing Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

To find out more about breast implant market data or procedure data, register online or email us at [email protected] for a U.S. Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices Market report brochure and synopsis.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: